Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Cue Biopharma, Inc. | cue-ex321_12.htm |
| EX-31.2 - EX-31.2 - Cue Biopharma, Inc. | cue-ex312_9.htm |
| EX-31.1 - EX-31.1 - Cue Biopharma, Inc. | cue-ex311_10.htm |
| EX-21 - EX-21 - Cue Biopharma, Inc. | cue-ex21_11.htm |
| EX-10.30 - EX-10.30 - Cue Biopharma, Inc. | cue-ex1030_792.htm |
| EX-10.28 - EX-10.28 - Cue Biopharma, Inc. | cue-ex1028_793.htm |
| EX-10.26 - EX-10.26 - Cue Biopharma, Inc. | cue-ex1026_791.htm |
| EX-10.10 - EX-10.10 - Cue Biopharma, Inc. | cue-ex1010_729.htm |
| EX-10.9 - EX-10.9 - Cue Biopharma, Inc. | cue-ex109_731.htm |
| EX-10.8 - EX-10.8 - Cue Biopharma, Inc. | cue-ex108_734.htm |
| EX-10.7 - EX-10.7 - Cue Biopharma, Inc. | cue-ex107_735.htm |
| EX-10.6 - EX-10.6 - Cue Biopharma, Inc. | cue-ex106_730.htm |
| EX-10.5 - EX-10.5 - Cue Biopharma, Inc. | cue-ex105_733.htm |
| EX-10.4 - EX-10.4 - Cue Biopharma, Inc. | cue-ex104_732.htm |
| EX-10.3 - EX-10.3 - Cue Biopharma, Inc. | cue-ex103_736.htm |
| 10-K - 10-K - Cue Biopharma, Inc. | cue-10k_20201231.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Nos. 333-229140 and 333-23957) on Form S-3 and Registration Statements (Nos. 333-224018, 333-230282 and 333-237140) on Form S-8 of Cue Biopharma, Inc. of our report dated March 9, 2021, relating to the consolidated financial statements of Cue Biopharma, Inc. and Subsidiary appearing in this Annual Report on Form 10-K of Cue Biopharma, Inc. for the year ended December 31, 2020.
/s/ RSM US LLP
Boston, Massachusetts
March 9, 2021